CRNX Stock Price Prediction 2026
Crinetics Pharmaceuticals, Inc.
$49.94
$-1.94
(-3.74%)
AI-powered price predictions based on fundamental analysis and growth projections
Last Updated: January 30, 2026
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
- Recent pattern: Doji - Indecision pattern
- Price near support at $50.69
MACD: Bearish
|
Volume: Slight_Distribution
Volume Trend: Slight_Distribution
Selling Pressure Present - Distribution pattern observed
Chaikin Money Flow (CMF):
-0.057
Money Flow Index (MFI):
47.8
Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.
Price Targets by Timeframe
AI-based growth projections (not Wall Street analyst targets)
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $52.70 | +5.5% |
| 90 Days | $58.58 | +17.3% |
| 6 Months | $67.22 | +34.6% |
| 1 Year | $84.50 | +69.2% |
More CRNX Analysis
CRNX Price Prediction Trendline
Scenario Analysis (1-Year Outlook)
Bull Case
30% Probability
$105.62
(+111.5%)
Best case scenario if strong fundamentals and market conditions align
Base Case
50% Probability
$84.50
(+69.2%)
Expected scenario based on current growth trajectory
Bear Case
20% Probability
$59.15
(18.4%)
Downside scenario if market headwinds or disappointing results
Technical Indicators
RSI (14)
46.6
Neutral
MACD Signal
Bearish
Trend
Downtrend
Money Flow (CMF)
-0.06
Key Fundamentals
P/S Ratio (TTM)
3427.30x
High Premium
Revenue Growth (QoQ)
1.6%
Market Cap
$5,261M
Analyst Target
$84.50
52-Week High
$51.91
52-Week Low
$49.75
Options Activity
Alert Score
85/100
Classification
Strong Alert
Unusual Activity
80.1
IV Spike
+101.0%
Recommendation: Strong unusual activity detected. Review for potential entry.
Investment Disclaimer:
These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.